Literature DB >> 19796745

A step in the right direction, but one size might not fit all.

Simon Noble.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19796745     DOI: 10.1016/S1470-2045(09)70293-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer.

Authors:  Ezgi Guler; Daniel A Smith; Bhanusupriya Somarouthu; Rahul Gujrathi; Nikhil H Ramaiya; Sree Harsha Tirumani
Journal:  Abdom Radiol (NY)       Date:  2020-03

2.  Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study.

Authors:  Patrizia Ferroni; Francesca Martini; Ilaria Portarena; Italia Grenga; Silvia Riondino; Francesca La Farina; Anastasia Laudisi; Fiorella Guadagni; Mario Roselli
Journal:  Support Care Cancer       Date:  2012-02-10       Impact factor: 3.603

3.  Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis.

Authors:  Eric T Alexander; Allyson R Minton; Candace S Hayes; Ashley Goss; Joanne Van Ryn; Susan K Gilmour
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.

Authors:  Sandro Barni; Roberto Labianca; Giancarlo Agnelli; Erminio Bonizzoni; Melina Verso; Mario Mandalà; Matteo Brighenti; Fausto Petrelli; Carlo Bianchini; Tania Perrone; Giampietro Gasparini
Journal:  J Transl Med       Date:  2011-10-20       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.